UTEP head coach Rodney Terry in critical condition after allergic reaction to meal.
UTEP head coach Rodney Terry in critical condition after allergic reaction to meal.
Tasmania has received rare summer snowfall, while other parts of Australia battle a heatwave.
(Bloomberg) -- China’s No. 2 smartphone maker Xiaomi Corp. has suspended trading of its Hong Kong shares after completing the city’s largest top-up placement on record.Xiaomi said in a Hong Kong exchange filing that trading would be halted Wednesday, without giving a reason. While the company has yet to disclose its stock sale, deal terms obtained by Bloomberg News showed it sold 1 billion shares in a top-up placement at HK$23.70 each, the bottom of a range, to raise $3.1 billion. That represents a 9.4% discount to its last closing price of HK$26.15.A representative for Xiaomi didn’t immediately reply to a request for comment on the trading suspension. Hong Kong’s stock exchange requires a company to apply for a trading halt if certain inside information has been made public before an official disclosure.Wednesday’s premarket auction showed the stock trading as low as HK$24.50, implying a drop of 6.1%.“We are still figuring out the reason for the suspension,” said Castor Pang, head of research at Core Pacific-Yamaichi International Hong Kong. “It’s definitely unusual because other companies which had share placements usually file the official announcements soon after pricing. It’s hard to know what’s going on.”Xiaomi also fetched $900 million through the sale of a seven-year, zero-coupon convertible bond, the terms showed. The proceeds will add to a war chest aimed at expanding its market share from competitor Huawei Technologies Co.Xiaomi shares have rallied 143% this year. Its stock slipped after it disclosed that its internet services revenue had grown at its slowest pace in three years in the quarter that ended September. It grabbed market share from Huawei when American sanctions deepened particularly in overseas markets from Europe to India.The proceeds from the equity placement will be used for business expansion, investments to increase market share and strategic ecosystem investments, the terms showed.Credit Suisse Group AG, Goldman Sachs Group Inc, JPMorgan Chase & Co. and Morgan Stanley are arranging Xiaomi’s offering.(Adds attempt to contact company, exchange rules, premarket trading and quote from third paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Singapore has given U.S. start-up Eat Just the greenlight to sell its lab-grown chicken meat, in what the firm says is the world's first regulatory approval for so-called clean meat that does not come from slaughtered animals. Plant-based meat options, popularised by Beyond Meat Inc and Impossible Foods, increasingly feature on supermarket shelves and restaurant menus. "The first-in-the-world regulatory allowance of real, high-quality meat created directly from animal cells for safe human consumption paves the way for a forthcoming small-scale commercial launch in Singapore," Eat Just said on Wednesday.
The photo purportedly shows an Australian soldier drinking beer from the prosthetic leg of a dead Taliban soldier.
Electronics giant Samsung Electronics announced a small reshuffle of senior executives on Wednesday without replacing its recently deceased chairman or changing top leadership positions including that of vice chairman Jay Y. Lee. Heir apparent Lee, whose father and Samsung Electronics chairman Lee Kun-hee passed away in October, is currently facing two separate trials that analysts say could land him in jail for a second time. With the trials' uncertain outcomes hanging over Lee, Samsung is seen taking its time before making big changes in leadership positions such as Lee rising to fill the vacant chairmanship, analysts said.
The Pharmaceutical Caps and Closures Market will grow by USD 2.43 bn during 2020-2024
Tim Paine and the chairman of Cricket Tasmania have rejected allegations from Channel Seven.
(Bloomberg) -- JD Health International Inc. raised HK$27 billion ($3.5 billion) after pricing Asia’s biggest health-care initial public offering at the top end of a marketed range.The unit of Chinese e-commerce operator JD.com Inc. priced its sale of 381.9 million shares at HK$70.58 apiece, according to terms for the deal obtained by Bloomberg. The company is due to start trading in Hong Kong on Dec. 8.The IPO is also the largest of this year’s first-time share sales in Hong Kong, excluding the second listing by JD Health’s parent company in June, according to data compiled by Bloomberg. It values the medical unit at $28.5 billion, according to the terms.The offering also surpasses the $2.3 billion share sale by Japan’s Otsuka Holdings Co. a decade ago to be Asia’s biggest listing in the health-care sector, the data show. The medical industry has seen a record wave of listings in Asia this year, spurred by strong investor demand amid the coronavirus pandemic.JD Health is the largest online health-care platform and online pharmacy by revenue in China, according to its prospectus. The company recorded revenues of 8.8 billion yuan ($1.34 billion) in the first half of this year, up from 5 billion yuan in the same period a year earlier.The company brought in six cornerstone investors for its IPO who agreed to subscribe for as much as $1.35 billion of stock, including Singapore sovereign wealth fund GIC Pte, Hillhouse Capital and BlackRock Inc.The company was marketing the shares at HK$62.80 to HK$70.58 each. Bank of America Corp., Haitong International Securities Group Ltd. and UBS Group AG are joint sponsors for JD Health’s IPO.(Updates with context and valuation in the third paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Khloe Kardashian stuns fans by sharing snap of herself wearing nothing but a pair of boots.
President Donald Trump has discussed pardoning three of his children and hispersonal attorney Rudy Giuliani before he leaves office and before any of themhave been charged with potential crimes, according to several reports onTuesday evening.
A warehouse in the US city of Baltimore may seem an unlikely place to help save the country from the Covid-19 pandemic, but Brian Gallizzo is prepared to do just that.
A Chinese robot probe launched to return lunar rocks to Earth has landed on the Moon, the government says.
England on Wednesday exited a month-long lockdown but most of the country remained under restrictions as a new regional system for cutting coronavirus infection rates kicked in.
Oil prices extended losses on Wednesday, hit by a surprise build in oil inventories in the United States and as OPEC and its allies left markets in limbo by delaying a formal meeting to decide whether to increase output in January. Brent crude oil futures were down by 27 cents, or 0.6%, at $47.15 a barrel by 0131 GMT, while West Texas Intermediate crude was down by 29 cents, or 0.7%, at $44.26. Industry data from the American Petroleum Institute showed U.S. crude inventories rose by 4.1 million barrels last week, compared with analysts' expectations in a Reuters poll for a draw of 2.4 million barrels.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Delta 9 Cannabis Inc. (“Delta 9” or the “Company”) (TSX:DN) (OTCQX: VRNDF) is pleased to announce that is has amended the terms of its previously announced offering of Equity Units (as defined below) under the terms of an amended agreement with Leede Jones Gable Inc. as the lead underwriter and sole bookrunner (the “Underwriter”), pursuant to which the Underwriter has agreed to purchase, on a bought-deal basis, 9,090,910 units (the “Equity Units”) for gross proceeds to the Company of $5,000,000.50 (the “Offering”) at a price of $0.55 per Equity Unit.Each Equity Unit will consist of common share of the Company (a “Common Share”) and one half (1/2) of a Common Share purchase warrant (each whole purchase warrant, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.70 (the “Exercise Price”) at any time up to thirty-six (36) months following Closing (as defined below).The Units will be offered by way of a short form prospectus to be filed in those provinces of Canada other than Quebec as the Underwriter may designate pursuant to National Instrument 44-101 – Short Form Prospectus Distributions and may be offered in the United States on a private placement basis pursuant to an appropriate exemption from the registration requirements under applicable U.S. law.The net proceeds from the Offering will be used for working capital and general corporate purposes.The closing of the Offering is expected to occur on or about the week of December 21, 2020 (the “Closing”) and is subject to the Company receiving all necessary regulatory approvals, including the approval of the Toronto Stock Exchange.About Delta 9 Cannabis Inc.Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "VRNDF". For more information, please visit https://invest.delta9.ca/.For further information, please contact:Investor & Media Contact: Ian Chadsey VP Corporate Affairs Mobile: 204-898-7722 E-mail: email@example.comCautionary Note Regarding Forward Looking Information:This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon Delta 9's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of Delta 9 to implement its business strategies; competition; crop failure; and other risks.Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Delta 9 does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Delta 9 to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Delta 9's Annual Information Form dated March 19, 2020 (the "AIF") and other disclosure documents of Delta 9 filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
Ange Postecoglou has celebrated extending his contract with J-League champions Yokohama F. Marinos by leading the club into the Asian Champions League last 16.
Premier Daniel Andrews says a comment from the Victorian ombudsman about funding is simply wrong.
'She started crying and admitted it was all lies.'
The international security body OSCE is expected to fill an unprecedented leadership vacuum, during meetings Thursday and Friday, after it failed to reappoint four of its top leaders in July.
Visible Supply Chain Management partnered with the U.S. Postal Service to ensure 18,000 COVID-19 test kits were shipped and delivered to consumers.